Letter to the Editor
Bone Marrow Transplantation (2007) 40, 83–84; doi:10.1038/sj.bmt.1705683; published online 23 April 2007
Successful allogeneic stem cell transplantation in second chronic-phase CML induced by the tyrosine kinase inhibitor nilotinib (AMN107) after blast crisis under imatinib
H Menzel1, N von Bubnoff1, A Hochhaus2, C Haferlach3, C Peschel1 and J Duyster1
- 1Third Medical Department, Technical University of Munich, Munich, Germany
- 2Third Medical Department, University Hospital of Mannheim, Mannheim, Germany
- 3Munich Leukemia Laboratory, Munich, Germany
Correspondence: H Menzel, E-mail: H.Menzel@LRZ.TU-Muenchen.de
Top of page
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
Leukemia Letter
